Cyclerion Therapeutics, Inc. (KRSA) vs Septerna, Inc. (SEPN)
Cyclerion Therapeutics, Inc. and Septerna, Inc. are both Biotechnology companies. Cyclerion Therapeutics, Inc. and Septerna, Inc. are of similar size ($1.8B and $1.7B). Septerna, Inc. grew revenue faster over the last twelve months: 13,520.1% against 30.8%. Cyclerion Therapeutics, Inc. has the higher net margin (0.00% vs −24.5%) and the higher return on invested capital (−115.4% vs −189.0%). Across the 15 metrics below, Septerna, Inc. leads on 8 and Cyclerion Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | KRSA | SEPN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (44.04%) | 0.00% |
| Net margin | 0.00% | (24.51%) | 0.00% |
| Free cash flow margin | 0.00% | 118.93% | 0.00% |
| Return on equity | (98.22%) | (6.34%) | (57.72%) |
| Return on assets | (82.29%) | (4.94%) | (49.22%) |
| Return on invested capital | (115.40%) | (189.01%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack